Expands Raman Spectroscopy Portfolio with In-Line Process Analytical Technology WALTHAM, Mass. -- Thermo Fisher Scientific Inc., the world leader in serving science, has completed its acquisition of MarqMetrix, a privately held developer of Raman-based spectroscopy solutions for in-line measurement. The terms of the deal were not disclosed. Based in Seattle, Washington, MarqMetrix provides innovative and [...]

Vienna – Lexogen, a leading provider of innovative next-generation sequencing solutions, is pleased to announce that it has successfully earnt ISO 13485:2016 certification from Quality Austria. This internationally recognized standard reflects Lexogen’s dedication to designing and delivering the highest quality products for the biotechnology and medical device industry. ISO 13485 is a stringent quality standard intended [...]

SOPHiA GENETICS technology to aid research associated with hereditary cancers and disorders BOSTON and LAUSANNE, Switzerland – SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space and a leader in data-driven medicine, today announced that Ankara Etlik City Hospital, the largest hospital in the capital city of Turkey, is live on the SOPHiA DDM™ [...]

Oxford, England -- Oxford Instruments today launches the world's first imaging detector to combine Backscattered Electron and X-ray imaging in a single technique – BEX. Unity enables researchers, scientists, and students to achieve instant visual and compositional sample analysis simultaneously in the Scanning Electron Microscope (SEM). Traditionally, determining the elemental makeup and composition of materials in [...]

Tempus, a leader in artificial intelligence and precision medicine, today introduces its standalone RNA next-generation sequencing assay, Tempus xR. xR is a whole transcriptome panel for solid tumors, reporting clinically relevant fusions for more than 100 targeted genes, as well as altered splicing for MET Exon 14 and EGFRvIII. Tempus has always understood the importance of [...]

Selective Suppression Probes- SSP™ SANTA CRUZ, CALIFORNIA, UNITED STATES -- RealSeq Biosciences1 has developed a targeted removal probe (Selective Suppression Probe- SSP™) approach to deplete undesired or over-abundant species from RNA samples, resulting in increased reads and greater sequencing depth for small RNAs/miRNAs of interest. Unwanted RNA species can dramatically reduce read depth of the RNAs that researchers [...]

IRVINE, Calif. -- Zymo Research, a leading innovation company for biomedical products and services has donated $25,000 to the Regents of the University of California to support the Center for Virus Research at the University of California, Irvine (UCI). "We are grateful for the generous support from Zymo Research," said Dr. Thomas Lane, Director Center for Virus Research. "This donation supports us in making [...]

Platform selected to accelerate precision fermentation workflows, to support more sustainable and cost-effective manufacturing for active ingredients in vitamins and bioactives Early results demonstrate significant savings in time and resources applicable across a wide range of synthetic biology applications Cambridge, UK, and Copenhagen, Denmark: Sphere Fluidics, a company developing single cell analysis systems underpinned by its [...]

·        Investment in new global headquarters forms part of ongoing growth plans ·        Bespoke lab and office space designed to foster innovation and collaboration with colleagues and customers Greater London, UK: H.E.L Group (H.E.L), a global developer and manufacturer of innovative laboratory tools for process optimization, safety, and scale-up, today announced it will relocate its Greater London global [...]

LEIDEN, the Netherlands -- MIMETAS, a global leader in human disease modeling announces that it has expanded its ongoing partnership with Astellas, a global pharmaceutical company, to include automation and application support. “We are truly honored by the trust of the Astellas team in our capabilities,” says Paul Vulto, CEO of MIMETAS. “Astellas is a true innovation leader that [...]